QA: Biofrontera Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001858685_2023_Biofrontera_Inc.pdf

Logs

Graph

Absolute values for 0001858685, Biofrontera Inc.

  xvar xval
0 AssetsCurrent 43,140,000
1 IntangibleAssetsNetIncludingGoodwill 3,032,000
2 PropertyPlantAndEquipmentNet 204,000
3 remainder_Assets 4,508,000
4 LiabilitiesCurrent 20,894,000
5 LiabilitiesNoncurrent 869,000
6 remainder_Liabilities 5,243,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 35,137,000
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 12,150,000
11 remainder_Revenues 28,674,000
12 remainder_NetIncome 17,973,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 50,884,000
1 Liabilities 27,006,000
2 Expenses 47,287,000
3 Revenues 28,674,000
4 StockholdersEquity 23,878,000
5 NetIncome -640,000
6 ComprehensiveNetIncome -640,000
7 BaseVar 85,912,000
8 EconomicCapitalRatio 1.04

Edgar->Model Mapping

Feature Distribution

Change over Time